Public preview. Funding rounds, founders, and growth signals require a free account.

AmpliPhi Biosciences Corp (ARMP)

Clinical-stage biotech developing targeted bacteriophage therapeutics for antibiotic-resistant infections.

GrowthBiotechGlen Allen, VA11-50 employees

Total raised

$70.6M

Last round

Equity

$13.0M · Mar 2015

Stage

Growth

Status

Active

Founders & team

Co-founder, CEO

Co-founder, CTO

Head of Engineering

Head of Sales

🔒

Free account unlocks founder names, LinkedIn profiles, and prior companies.

Web traffic

Search interest

Social followers

Glassdoor rating

News mentions

Gov contracts

🔒

Free account unlocks 5 full profiles per day. Pro removes the limit.

Get notified the moment AmpliPhi Biosciences Corp (ARMP) files a new round, hires execs, or shows traction signals.

About this data

FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.